TXG insider files Form 144 to sell 7,393 RSU shares valued at $99K

Rhea-AI Filing Summary

10x Genomics (TXG) filed a Form 144 reporting a proposed sale under Rule 144 of 7,393 shares of common stock with an aggregate market value of $99,140.13, planned on 08/22/2025 on NASDAQ through Morgan Stanley Smith Barney LLC.

The shares were acquired as a Restricted Stock Unit grant from the issuer on 08/21/2025 totaling 20,657 units and paid as services rendered. The filer also sold 7,485 shares on 05/22/2025 for gross proceeds of $62,120.26. The notice includes the standard representation that the selling person is not aware of undisclosed material adverse information.

Positive

• Clear disclosure of broker, share count, and aggregate market value facilitates market transparency
• Securities originated from an RSU grant, indicating the sale is monetization of compensation rather than a secondary capital raise

Negative

• Insider selling activity of 7,393 shares valued at $99,140.13 could modestly increase floating supply
• No trading-plan date disclosed in the filing, so the sale does not show an explicit Rule 10b5-1 adoption date

Insights

Securities Analyst

TL;DR: Insider plans to sell roughly $99k of newly vested RSU shares; transaction appears routine and follows prior small sale.

The Form 144 discloses a proposed Rule 144 sale of 7,393 common shares valued at about $99k, sourced from a Restricted Stock Unit grant delivered one day earlier. The close timing between grant/vesting and the proposed sale is documented here, and a prior sale of 7,485 shares in May for $62k is also reported. From a trading-impact perspective this is modest relative to typical market caps for publicly listed life sciences equipment companies; the filing signals routine monetization of compensation rather than a major liquidity event.

Corporate Governance Expert

TL;DR: Disclosure complies with Rule 144 mechanics; the filer affirms absence of undisclosed material information.

The notice records the required broker, share counts, and acquisition history tied to an RSU grant, meeting Form 144 disclosure obligations. The signature representation about no material non-public information is included. This filing documents insider selling activity consistent with standard post-vesting disposal; there is no disclosure here of any trading-plan adoption date or other governance details that would indicate a pre-established sale program.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Services 200 W Civic Center Dr., 4th Floor Sandy UT 84070	7393	99140.13	114411468	08/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/21/2025	Restricted Stock Unit Grant	Issuer			20657	08/21/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin J. Hindson 6230 Stoneridge Mall Road Pleasanton CA 94588	Common Stock	05/22/2025	7485	62120.26

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Form 144 filed for TXG report?

The filing reports a proposed Rule 144 sale of 7,393 TXG common shares with an aggregate market value of $99,140.13 to be executed on 08/22/2025 on NASDAQ.

How were the shares being sold acquired?

The shares were acquired as a Restricted Stock Unit grant from the issuer on 08/21/2025, totaling 20,657 units, with payment listed as services rendered.

Who is the broker handling the sale?

The broker listed is Morgan Stanley Smith Barney LLC Executive Services, with the address shown in Sandy, UT.

Has the filer sold TXG shares recently?

Yes. The filer sold 7,485 common shares on 05/22/2025 for gross proceeds of $62,120.26.

Does the filing state there is undisclosed material information?

The filer affirms by signature that they do not know of any material adverse information about the issuer that has not been publicly disclosed.